Regulatory14 May 2026, 12:44 pm
Suven Life Sciences: Monitoring Agency Report for Q4 FY26
AI Summary
Suven Life Sciences Ltd has released the Monitoring Agency Report by CRISIL Ratings Limited for the quarter ended March 31, 2026, concerning the utilization of proceeds from the Preferential Issue. The report, issued in compliance with SEBI regulations, confirms no deviations from the intended objectives of the issue. CRISIL Ratings declares an objective view based on provided information, disclaiming audit responsibilities and liability for losses from the report's use.
Key Highlights
- CRISIL Ratings issued the Monitoring Agency Report for Suven Life Sciences for Q4 FY26.
- The report confirms compliance with SEBI regulations regarding the utilization of Preferential Issue proceeds.
- CRISIL Ratings states no deviations from the objects of the issue.
- The report is based on information provided by the issuer and believed to be accurate.
- CRISIL Ratings disclaims responsibility for losses arising from the use of the report's information.
Price Impact
More from SUVEN